Important announcement concerning Temple Health and Keystone First. Our provider agreement with Keystone First is scheduled to end on July 31st. Click the link below to learn about your options for continuing care at Temple Health.

Learn More
800-TEMPLE-MED Schedule Appointment
SEARCH TEMPLE HEALTH

Evaluation of the Safety and Efficacy of TLD in Patients With COPD (AIRFLOW-3)

view all Clinical Trials

Overview

The purpose of this study is to confirm the safety and efficacy of the Nuvaira Lung Denervation System (Nuvaira System) in the treatment of chronic obstructive pulmonary disease (COPD).

Clinical Trial Information

Protocol

TIRB#: 25796, WIRB#:20190348

Phase

n/a

Condition(s)

Chronic Obstructive Pulmonary Disease (COPD)

Investigator

Gerard Criner, MD

Coordinator

Helga Criner, Pete Gavin, Ruth Marcus

Visit clinicaltrials.gov for full description.

Contact

For more information about this trial or to inquire about eligibility, email [email protected] or call 215-707-1359.

Full Title

Evaluation of the Safety and Efficacy of TLD in Patients With COPD (AIRFLOW-3)